Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07001098 · ClinicalTrials.gov registry record · Phase 2
Amino Acids for Cardiac Surgery Associated AKI
A Phase 2 study, sponsored by Stanford University.
- Not yet
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
NCT07001098: Clinical Trial Phase 2 study, sponsored by Stanford University.
NCT07001098 is a Phase 2 study that has not yet begun recruiting, run by Stanford University. The registered enrollment target is 30 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07001098, a Phase 2 study, has not yet begun recruiting, sponsored by Stanford University.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the feasibility of amino acid infusions in pediatric cardiac surgery patients.
Interventions
- DRUG Placebo
- DRUG Amino Acids
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-09 |
| Est. Completion | 2026-11 |
| Phase | Phase 2 |
What is known before NCT07001098 opens enrollment
NCT07001098 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (77% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT07001098 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07001098 about?
NCT07001098 is a clinical study titled "Amino Acids for Cardiac Surgery Associated AKI". The purpose of this study is to assess the feasibility of amino acid infusions in pediatric cardiac surgery patients.
What is the current status of trial NCT07001098?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2025-09. Estimated completion is 2026-11.
What interventions are being tested in trial NCT07001098?
The interventions under investigation include: Placebo (DRUG), Amino Acids (DRUG).
Who is sponsoring clinical trial NCT07001098?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07001098's enrollment target sits among peer trials
30 1582nd of 2000 higher than 332 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia